Literature DB >> 6892774

Sucralfate, a basic aluminum salt of sucrose sulfate. II. Inhibition of peptic hydrolysis as it results from sucrose sulfate interaction with protein substrate, serum albumins.

R Nagashima, N Yoshida, N Terao.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6892774

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


× No keyword cloud information.
  6 in total

1.  A novel evaluation method of gastric mucoadhesive property in vitro and the mucoadhesive mechanism of tetracycline-sucralfate acidic complex for eradication of Helicobacter pylori.

Authors:  Shoichi Higo; Kazutomo Ori; Hirofumi Takeuchi; Hiromitsu Yamamoto; Tomoaki Hino; Yoshiaki Kawashima
Journal:  Pharm Res       Date:  2004-03       Impact factor: 4.200

2.  Relationship between gastroprotective effect of locally acting antiulcer agent ecabet sodium and its binding to gastric mucosa in rats. Comparison with sucralfate.

Authors:  M Kinoshita; K Yamasaki; Y Kokusenya; H Tamaki
Journal:  Dig Dis Sci       Date:  1995-03       Impact factor: 3.199

Review 3.  Sucralfate. A review of its pharmacodynamic properties and therapeutic use in peptic ulcer disease.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-03       Impact factor: 9.546

4.  Effects of an antiulcer drug, sucralfate (a basic aluminum salt of sulfated disaccharide), on experimental gastric lesions and gastric secretion in rats.

Authors:  S Okabe; K Takeuchi; H Kunimi; M Kanno; M Kawashima
Journal:  Dig Dis Sci       Date:  1983-11       Impact factor: 3.199

5.  Pharmacological manipulation of gastric juice: thrombelastographic assessment and implications for treatment of gastrointestinal haemorrhage.

Authors:  S E Patchett; D P O'Donoghue
Journal:  Gut       Date:  1995-03       Impact factor: 23.059

6.  Selective binding of sucralfate to gastric ulcer in man.

Authors:  S Nakazawa; R Nagashima; I M Samloff
Journal:  Dig Dis Sci       Date:  1981-04       Impact factor: 3.199

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.